SANGAMO THERAPEUTICS, INC. Operating Lease Cost
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Operating Lease Cost of $5.72 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-30
- SANGAMO THERAPEUTICS, INC. operating lease, cost for the quarter ending 2021-06-30 was $2.70M, a 4.86% increase year-over-year.
- SANGAMO THERAPEUTICS, INC. operating lease, cost for the quarter ending 2021-03-31 was $2.70M, a 3.85% increase year-over-year.
- SANGAMO THERAPEUTICS, INC. operating lease, cost for the quarter ending 2020-12-31 was $2.70M, a 3.85% increase year-over-year.
- SANGAMO THERAPEUTICS, INC. operating lease, cost for the quarter ending 2020-09-30 was $4.00M, a 53.85% increase year-over-year.
- SANGAMO THERAPEUTICS, INC. operating lease, cost for fiscal 2025 was $5.72M, a 10.31% decline from fiscal 2024.
- SANGAMO THERAPEUTICS, INC. operating lease, cost for fiscal 2024 was $6.38M, a 32.35% decline from fiscal 2023.
- SANGAMO THERAPEUTICS, INC. operating lease, cost for fiscal 2023 was $9.42M, a 14.56% decline from fiscal 2022.
- SANGAMO THERAPEUTICS, INC. operating lease, cost for fiscal 2022 was $11.03M, a 1.75% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 6 month as first filed | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $5.72M 10-K · filed 2026-03-30 | |||||
| 2024-12-31 | $6.38M 10-K · filed 2026-03-30 | |||||
| 2023-12-31 | $9.42M 10-K · filed 2025-03-17 | |||||
| 2022-12-31 | $11.03M 10-K · filed 2024-03-13 | |||||
| 2021-12-31 | $10.84M 10-K · filed 2023-02-23 | |||||
| 2021-06-30 | $2.70M 10-Q · filed 2021-08-05 | $5.38M 10-Q · filed 2021-08-05 | $8.10M derived: sum of 3 quarters · filed 2022-02-24 | $12.10M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2021-03-31 | $2.70M 10-Q · filed 2021-05-04 | $5.40M derived: sum of 2 quarters · filed 2022-02-24 | $9.40M derived: sum of 3 quarters · filed 2022-02-24 | $11.97M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $6.70M derived: sum of 2 quarters · filed 2022-02-24 | $9.27M derived: sum of 3 quarters · filed 2022-02-24 | $10.40M 10-K · filed 2022-02-24 | ||
| 2020-09-30 | $4.00M 10-Q · filed 2020-11-04 | $6.57M derived: sum of 2 quarters · filed 2021-08-05 | $7.70M 10-Q · filed 2020-11-04 | $11.77M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-06-30 | $2.57M 10-Q · filed 2021-08-05 | $2.60M 10-Q · filed 2020-08-05 | $5.14M 10-Q · filed 2021-08-05 | $5.10M 10-Q · filed 2020-08-05 | $7.77M derived: sum of 3 quarters · filed 2021-08-05 | $10.37M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $2.60M 10-Q · filed 2021-05-04 | $5.20M derived: sum of 2 quarters · filed 2021-05-04 | $7.80M derived: sum of 3 quarters · filed 2021-05-04 | $9.40M derived: sum of 4 quarters · filed 2021-05-04 | ||
| 2019-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $5.20M derived: sum of 2 quarters · filed 2020-02-28 | $6.80M derived: sum of 3 quarters · filed 2020-02-28 | $7.90M 10-K · filed 2020-02-28 | ||
| 2019-09-30 | $2.60M 10-Q · filed 2019-11-06 | $4.20M derived: sum of 2 quarters · filed 2019-11-06 | $5.30M 10-Q · filed 2019-11-06 | |||
| 2019-06-30 | $1.60M 10-Q · filed 2019-08-07 | $2.80M 10-Q · filed 2019-08-07 | ||||
| 2019-03-31 | $1.20M 10-Q · filed 2019-05-08 |